title: Viral clearance using traditional, well-understood unit operations: session 1.2. Anion exchange chromatography; and session 1.3. Protein a chromatography.
authors.affiliation: Merck, Sharp, and Dohme, BioProcess Development, 2015 Galloping Hill Road, Mailstop K15-2-H206, Kenilworth, NJ 07033 david_roush@merck.com.
authors.forename: David
authors.initials: D
authors.lastname: Roush
mesh_terms: D000818:Animals; D000838:Anions; D000911:Antibodies, Monoclonal / Q000737:chemistry / Q000494:pharmacology*; D000998:Antiviral Agents / Q000737:chemistry / Q000494:pharmacology*; D002626:Chemistry, Pharmaceutical / Q000379:methods* / Q000639:trends; D002852:Chromatography, Ion Exchange / Q000379:methods; D006801:Humans; D019562:Viral Load / Q000187:drug effects* / Q000502:physiology; D014764:Viral Proteins / Q000032:analysis* / Q000037:antagonists & inhibitors
chemical_list: D000838:Anions; D000911:Antibodies, Monoclonal; D000998:Antiviral Agents; D014764:Viral Proteins
keywords: AEX; Affinity; BVDV; CHOP; Competitive adsorption; Flowthrough; LDAO; MMV; PP7; Partitioning; Phage; PrV; Protein A; Reo; Triton X-100; Virus; XMuLV; φX174